ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
January 2026
Latest News
Mirion announces appointments
Mirion Technologies has announced three senior leadership appointments designed to support its global nuclear and medical businesses while advancing a company-wide digital and AI strategy. The leadership changes come as Mirion seeks to advance innovation and maintain strong performance in nuclear energy, radiation safety, and medical applications.
Kenneth L. Ferguson
Nuclear Technology | Volume 42 | Number 1 | January 1979 | Pages 5-12
Technical Paper | Reactor | doi.org/10.13182/NT79-A32157
Articles are hosted by Taylor and Francis Online.
Radioactive effluents and concentrations expected from the Clinch River Breeder Reactor (CRBR) during normal operation have been assessed. Developed were the individual off-site dose values as well as population doses within an 80-km (50-mile) radius of the proposed facility. Comparison has been with the as low as reasonably achievable (ALARA) exposure objective as in 10CFR50, Appendix I, of the Code of Federal Regulations. All estimated releases are well within the concentration limits found in 10CFR20. The calculated doses to individuals are consistently lower than values of 10CFR50, Appendix I. Population exposures are a very small fraction of that due to background radiation. Exposures due to CRBR effluents are also in conformity with cost-benefit arguments of the ALARA objective. Measures are in place to follow the design progression and operation of the facility to retain the ALARA aspect of the doses associated with the effluent releases.